10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus

Clinical Trial ID: NCT00568997

This study will examine the risk of systemic malignancies in pediatric patients with atopic dermatitis exposed to Elidel 1% cream.

Registry study to examine the risk of systemic malignancies in pediatric patients with atopic dermatitis exposed to Elidel 1% cream.

Inclusion Criteria: - males and females - greater than or equal to 2 years and less than or equal to 17 years at enrollment - diagnosis of atopic dermatitis (confirmed by treating physician) - applied pimecrolimus cream 1 % 6 weeks out of past 24 weeks Exclusion Criteria: - past or present history of systemic malignancy, skin malignancy, or lymphoproliferative disease - past or present use of oral immunosuppressive therapy

Start Date
2005-06-27
Last Updated
2017-12-08
Sponsor
Clinical Research Computing Unit (University of Pennsylvania)
Condition Name
Atopic Dermatitis

Learn about this trial.

Check the eligibility requirements, study details, and more.

Visit clinicaltrials.gov

Different trials target different symptoms, condition types, and patients. Learn more about other emergeing treatments being investigated now.

Clinicaltrials.gov

Scratch Behavior Under Standard of Care

Wrist-worn accelerometers and associated data analysis platforms will provide quantitative and qualitative knowledge regarding the action of scratching and sleep quantity in a symptomatic Atopic Dermatitis...

Trial Type

Observational

Sponsorship

Boston University

Clinicaltrials.gov

Immunogenetic Profiling of Dupilumab for the Treatment of Atopic...

This is a single-arm, open-label study to examine the effect of dupilumab on the immunologic and genetic environment within atopic dermatitis skin lesions.

Trial Type

Interventional

Trial Phase

Phase 4

Sponsorship

Sanofi

Clinicaltrials.gov

A Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric...

The purpose of this study is to evaluate the safety, tolerability and the pharmacokinetics (PK) of topical ruxolitinib cream applied to pediatric subjects (age ≥ 2 to 17 years) with atopic dermatitis (AD).

Trial Type

Interventional

Trial Phase

Phase 1

Sponsorship

Incyte Corporation

Clinicaltrials.gov

Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema,...

This is a tissue, urine, and blood banking protocol for cutaneous t-cell lymphoma (CTCL), eczema, and atopic dermatitis patients for current and future research.

Trial Type

Observational

Sponsorship

University of Pittsburgh

Clinicaltrials.gov

Study in Subjects With Moderate Atopic Dermatitis

This is a Phase 2, randomized, double-blind, vehicle-controlled, parallel-group study to evaluate the safety and efficacy of ALX-101 Gel 5% and a matching ALX-101 Gel Vehicle when applied topically twice daily...

Trial Type

Interventional

Trial Phase

Phase 2

Sponsorship

Ralexar Therapeutics, Inc.

Clinicaltrials.gov

Study of the Safety, Tolerability and Efficacy of BTX 1204 in...

This is a randomized, double-blind, vehicle-controlled, Phase 2 study in subjects with moderate AD.

Trial Type

Interventional

Trial Phase

Phase 2

Sponsorship

Botanix Pharmaceuticals

Clinicaltrials.gov

The Impact of Dupilumab on Quality of Life in Moderate to Severe...

This is a single-arm, open-label study, which will examine the effect of dupilumab on quality of life in atopic dermatitis patients.

Trial Type

Interventional

Trial Phase

Phase 4

Sponsorship

Regeneron Pharmaceuticals

Clinicaltrials.gov

Etiology of Eczema Herpeticum (EH)

Atopic dermatitis, also called eczema, is a disease with dry, scaly, itchy skin. Those with atopic dermatitis may have complications from skin infections such as eczema herpeticum after herpes simplex virus...

Trial Type

Observational

Sponsorship

Atopic Dermatitis Research Network

Clinicaltrials.gov

Beginning Assessment of Cutaneous Treatment Efficacy of Roseomonas in...

Background: Atopic dermatitis (AD) is a skin disease also called eczema. It is common in children and sometimes gets better on its own. However, chronic AD may cause asthma, food allergies, eye infections, and...

Trial Type

Interventional

Trial Phase

Phase 1/Phase 2

Sponsorship

National Institute of Allergy and Infectious Diseases (NIAID)

Clinicaltrials.gov

Improvement of Short Term Outcome of Mild to Moderate Atopic...

This trial is a single-center two arm, open label observational prospective study, that will evaluate the safety and efficacy of crisaborole ointment, 2% alone compared to a combination therapy of crisaborole...

Trial Type

Observational

Sponsorship

Pfizer

Clinicaltrials.gov

The Role of Bathing Additives in the Treatment of Pediatric Atopic...

To evaluate the efficacy of water bath, water + bleach, and water + vinegar (acetic acid) in the treatment of atopic dermatitis (eczema)

Trial Type

Interventional

Trial Phase

N/A

Sponsorship

HealthPartners Institute

Clinicaltrials.gov

A Community-based Assessment of Skin Care, Allergies, and Eczema

Atopic dermatitis (AD) affects over 9 million children in the U.S. and often heralds the development of asthma, food allergy, skin infections and neurodevelopmental disorders. Recent advances identify skin...

Trial Type

Interventional

Trial Phase

N/A

Sponsorship

Duke University

Clinicaltrials.gov

A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the...

This phase 2b study is designed to evaluate the safety and efficacy of tezepelumab as a monotherapy and explore its efficacy as adjunct therapy in subjects with moderate-to-severe AD.

Trial Type

Interventional

Trial Phase

Phase 2

Sponsorship

AstraZeneca

Clinicaltrials.gov

Evaluating the Effect of Bathing Additives in Atopic Dermatitis

This proposed project will be an open-label, split-arm, randomized controlled pilot study. Up to 60 patients diagnosed with atopic dermatitis (eczema) will be enrolled in the study. The purpose of this study...

Trial Type

Interventional

Trial Phase

N/A

Sponsorship

University of Arizona

Clinicaltrials.gov

A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI...

This 4-week study will evaluate the safety and efficacy of crisaborole ointment 2%; crisaborole vehicle; topical corticosteroid and topical calcineurin inhibitor, applied twice daily (BID) in subjects who are...

Trial Type

Interventional

Trial Phase

Phase 4

Sponsorship

Pfizer

Clinicaltrials.gov

Evaluating the Effects of Cleansers on the Skin

This will be a single visit study that will take approximately 2 hours. Up to 50 subjects (up to 25 healthy subjects, and up to 25 subjects with AD) from BUMC dermatology clinics will be enrolled in this study...

Trial Type

Interventional

Trial Phase

N/A

Sponsorship

University of Arizona

Clinicaltrials.gov

Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate...

Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects

Trial Type

Interventional

Trial Phase

Phase 3

Sponsorship

Bausch Health Americas, Inc.

Clinicaltrials.gov

SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients"

Primary Objective: To evaluate the effect of dupilumab on sleep quality in adult patients with moderate to severe atopic dermatitis (AD) Secondary Objectives: To evaluate the effect of dupilumab on objective...

Trial Type

Interventional

Trial Phase

Phase 4

Sponsorship

Regeneron Pharmaceuticals

Clinicaltrials.gov

Study to Evaluate the Efficacy and Safety of Oral Difelikefalin...

This is a multicenter, randomized, double-blind, 4-arm, placebo-controlled study to evaluate the efficacy and safety of twice-daily (BID) oral difelikefalin (CR845) in adult subjects with atopic dermatitis...

Trial Type

Interventional

Trial Phase

Phase 2

Sponsorship

Cara Therapeutics, Inc.

Clinicaltrials.gov

Monitoring Of Scratch Via Accelerometry In Children

Sleep sensors, wrist worn accelerometers, polysomnography (PSG), and associated data analysis platforms would provide quantitative and qualitative knowledge regarding the action of scratching and sleep...

Trial Type

Observational

Sponsorship

Boston University

Clinicaltrials.gov

Steroid-reducing Effects of Crisaborole

Atopic dermatitis, or eczema, is a chronic skin condition affecting many children. Crisaborole is a non-steroid topical medication which is FDA approved for children aged 2 and older for eczema. This research...

Trial Type

Interventional

Trial Phase

Phase 4

Sponsorship

Pfizer

Clinicaltrials.gov

Bone Health in Patients With Atopic Dermatitis

This study examines the bone health in children with atopic dermatitis

Trial Type

Observational

Sponsorship

Pediatric Dermatology Research Alliance

Clinicaltrials.gov

JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With...

This is a randomized, double blind, placebo controlled, parallel group, Phase 3 study to evaluate the efficacy and safety of PF 04965842 in adolescent participants 12 to <18 years of age with moderate to...

Trial Type

Interventional

Trial Phase

Phase 3

Sponsorship

Pfizer

Clinicaltrials.gov

ASPIRE: PROs & Caregiver Burden in Children With Atopic Dermatitis

This is an open-label, randomized, cross-sectional study to monitor the effects of crisaborole and tacrolimus 0.03% on patient-reported outcomes and caregiver burden in children (ages 5 to 12 years, inclusive)...

Trial Type

Interventional

Trial Phase

Phase 3

Sponsorship

University of Rochester

Clinicaltrials.gov

Bleach vs. Bubbles: Assessing the Impact of the Bathroom Environment...

Purpose: Evaluate the impact of cleaning the bathroom environment on the severity of eczema. Determine if part of the efficacy of bleach baths may be in cleaning the bathroom. Record data on the process in...

Trial Type

Interventional

Trial Phase

N/A

Sponsorship

University of North Carolina, Chapel Hill

Clinicaltrials.gov

A Study Investigating the Efficacy, Safety, and PK Profile of ANB020...

This study is designed to evaluate the efficacy, safety, and pharmacokinetic (PK) profiles of multiple doses of ANB020 in subjects with atopic dermatitis (AD).

Trial Type

Interventional

Trial Phase

Phase 2

Sponsorship

AnaptysBio, Inc.

Clinicaltrials.gov

Topical Application of BMX-010 in Subjects With Atopic Dermatitis and...

This is a randomized, placebo-controlled Phase 2 trial consisting of up to 300 subjects with either psoriasis or atopic dermatitis. In this trial BMX-010 will be topically applied twice daily for up to 28 days.

Trial Type

Interventional

Trial Phase

Phase 2

Sponsorship

BioMimetix JV, LLC

Clinicaltrials.gov

Efficacy and Safety of IDP-124 Lotion

Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects

Trial Type

Interventional

Trial Phase

Phase 3

Sponsorship

Bausch Health Americas, Inc.

Clinicaltrials.gov

Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis

Atopic dermatitis (AD), also known as eczema, is the most common inflammatory skin disorder of children, affecting 10-20% of children and 1-2% of adults. This skin disorder can be associated with unbearable...

Trial Type

Observational

Sponsorship

Icahn School of Medicine at Mount Sinai

10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus

Description

Criteria

Start Date

Last Updated

Sponsor

Condition Name

Learn about this trial.

Related Trials

Clinicaltrials.gov

Scratch Behavior Under Standard of Care

Clinicaltrials.gov

Immunogenetic Profiling of Dupilumab for the Treatment of Atopic...

Clinicaltrials.gov

A Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric...

Clinicaltrials.gov

Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema,...

Clinicaltrials.gov

Study in Subjects With Moderate Atopic Dermatitis

Clinicaltrials.gov

Study of the Safety, Tolerability and Efficacy of BTX 1204 in...

Clinicaltrials.gov

The Impact of Dupilumab on Quality of Life in Moderate to Severe...

Clinicaltrials.gov

Etiology of Eczema Herpeticum (EH)

Clinicaltrials.gov

Beginning Assessment of Cutaneous Treatment Efficacy of Roseomonas in...

Clinicaltrials.gov

Improvement of Short Term Outcome of Mild to Moderate Atopic...

Clinicaltrials.gov

The Role of Bathing Additives in the Treatment of Pediatric Atopic...

Clinicaltrials.gov

A Community-based Assessment of Skin Care, Allergies, and Eczema

Clinicaltrials.gov

A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the...

Clinicaltrials.gov

Evaluating the Effect of Bathing Additives in Atopic Dermatitis

Clinicaltrials.gov

A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI...

Clinicaltrials.gov

Evaluating the Effects of Cleansers on the Skin

Clinicaltrials.gov

Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate...

Clinicaltrials.gov

SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients"

Clinicaltrials.gov

Study to Evaluate the Efficacy and Safety of Oral Difelikefalin...

Clinicaltrials.gov

Monitoring Of Scratch Via Accelerometry In Children

Clinicaltrials.gov

Steroid-reducing Effects of Crisaborole

Clinicaltrials.gov

Bone Health in Patients With Atopic Dermatitis

Clinicaltrials.gov

JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With...

Clinicaltrials.gov

ASPIRE: PROs & Caregiver Burden in Children With Atopic Dermatitis

Clinicaltrials.gov

Bleach vs. Bubbles: Assessing the Impact of the Bathroom Environment...

Clinicaltrials.gov

A Study Investigating the Efficacy, Safety, and PK Profile of ANB020...

Clinicaltrials.gov

Topical Application of BMX-010 in Subjects With Atopic Dermatitis and...

Clinicaltrials.gov

Efficacy and Safety of IDP-124 Lotion

Clinicaltrials.gov

Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis